Mohamad-Reza Aghanoori | Neurodegenerative Disorders | Best Researcher Award

Dr. Mohamad-Reza Aghanoori | Neurodegenerative Disorders | Best Researcher Award

Dr. Mohamad-Reza Aghanoori, National Institute of Genetic Engineering and Biotechnology,  Iran.

Dr. Mohamad-Reza Aghanouri is a distinguished neuroscientist and molecular medicine expert whose academic journey spans Iran and Canada. Beginning with foundational training in genetics and human biology, he has advanced into a dynamic career focused on translational neuroscience, particularly the genetic regulation of neurodevelopmental and neurodegenerative disorders. His doctoral and postdoctoral research have contributed significant insights into insulin/IGF-1 signaling, mitochondrial function, and gene expression related to autism and diabetic neuropathy.

Profile

Google Scholar

🎓 Early Academic Pursuits

Mohamad-Reza Aghanouri embarked on his academic journey with a B.Sc. in Cellular and Molecular Biology–Genetics from Shahid Chamran University of Ahvaz, Iran, in 2009. His keen interest in the intricate mechanics of human biology led him to pursue an M.Sc. in Human Genetics at Shiraz University of Medical Sciences, where he explored non-invasive techniques for early sex determination through free fetal DNA analysis. His growing passion for neuroscience and genetics culminated in a Ph.D. from the University of Manitoba, Canada, where he studied at the Department of Pharmacology and Therapeutics and the Division of Neurodegenerative Disorders. His doctoral thesis, focused on insulin/IGF-1 regulation of mitochondrial function in diabetic neuropathy, laid a strong foundation for a dynamic career in translational neurogenetics.

🧬 Professional Endeavors in Translational Neuroscience

Dr. Aghanouri’s postdoctoral work reflects a robust engagement with translational neuroscience and molecular medicine. From 2019 to 2024, he served as a postdoctoral fellow at the Department of Medical Genetics, Cumming School of Medicine, University of Calgary, under the mentorship of Dr. Guang Yang. His research investigated translational regulation of genes implicated in brain development, especially in autism spectrum disorders and rare neurodevelopmental conditions. Prior to that, he worked with Prof. Paul Fernyhough in Winnipeg, Canada, where he examined the role of IGF-1 in ATP production in sensory neurons under diabetic stress conditions. His diverse experience also includes a pivotal R&D advisory role at Roya Bio Gene Company in Tehran, showcasing his versatility across both academic and industrial biosciences.

🔬 Contributions and Research Focus

Dr. Aghanouri’s research contributions bridge the realms of neurodevelopment, metabolism, and genetic regulation. He has delved into the complex interplay between growth factors like IGF-1 and mitochondrial dynamics, particularly in relation to diabetic neuropathy. At the University of Calgary, his postdoctoral investigations explored the molecular pathways influencing neurodevelopmental disorders, positioning his work at the intersection of genomics and neuroscience. His methodological expertise spans cellular models, gene expression analysis, and translational bioinformatics, underscoring a commitment to discovering mechanisms that translate molecular findings into therapeutic insights.

🏆 Accolades and Recognition

Over the course of his academic and research career, Dr. Aghanouri has amassed a commendable list of honors. He received the prestigious CIHR postdoctoral fellowship (CA$40,000 annually, plus research allowance), along with additional fellowships from the Alberta Children’s Hospital Research Institute and the Cumming School of Medicine. Notably, he clinched first place in the Striking Image Competition at the University of Calgary and was honored by the BoniadMelliNokhbegan Foundation for his exceptional research talent. He has also earned multiple research grants from Iranian institutions in 2023 and 2024, reflecting his cross-border research impact and trust among funding bodies.

📚 Institutional Leadership and Influence

In 2024, Dr. Aghanouri was appointed as the Head of the Library, Documentation, Scientometrics, and Publication Center at the National Institute of Genetic Engineering and Biotechnology (NIGEB) in Tehran. He also holds a faculty position in the Department of Molecular Medicine at NIGEB. These roles position him as a key academic leader in Iran’s scientific community, where he not only continues his research but also shapes institutional research strategies, publication ethics, and scientific communication infrastructures. His work contributes significantly to Iran’s national bioscience and health research priorities.

🌍 Impact and Global Engagement

With academic roots in Iran and a decade of research training in Canada, Dr. Aghanouri exemplifies international scientific collaboration. His work addresses global health concerns, such as diabetes-induced neuropathies and neurodevelopmental disorders like autism, thus resonating with both clinical and scientific audiences worldwide. Through his active participation in conferences, poster competitions, and collaborative projects, he serves as a bridge between Iranian biotechnology advancements and the international research community.

🔮 Legacy and Future Contributions

Looking ahead, Dr. Aghanouri is poised to further advance the fields of molecular neurogenetics and translational medicine. His ongoing research is expected to uncover novel genetic mechanisms underlying brain development and metabolic dysfunctions. As a faculty member and research leader, he is mentoring the next generation of Iranian scientists while enhancing the global understanding of complex neurological diseases. His integrated approach to research, policy, and education ensures that his legacy will be one of both scientific innovation and institutional transformation.

Publication

 

  • Betulin and its derivatives as novel compounds with different pharmacological effects
    S Amiri, S Dastghaib, M Ahmadi, P Mehrbod, F Khadem, H Behrouj, …
    2020

 

  • Oxidized phosphatidylcholines trigger ferroptosis in cardiomyocytes during ischemia-reperfusion injury
    A Stamenkovic, KA O’Hara, DC Nelson, TG Maddaford, AL Edel, …
    2021

 

  • Insulin-like growth factor-1 activates AMPK to augment mitochondrial function and correct neuronal metabolism in sensory neurons in type 1 diabetes
    MR Aghanoori, DR Smith, S Shariati-Ievari, A Ajisebutu, A Nguyen, …
    2019

 

  • The ER stress/UPR axis in chronic obstructive pulmonary disease and idiopathic pulmonary fibrosis
    M Aghaei, S Dastghaib, S Aftabi, MR Aghanoori, J Alizadeh, P Mokarram, …
    2020

 

  • MiRNA molecular profiles in human medical conditions: Connecting lung cancer and lung development phenomena
    MR Aghanoori, B Mirzaei, M Tavallaei
    2014

 

  • Mechanisms targeting the unfolded protein response in asthma
    S Dastghaib, PS Kumar, S Aftabi, G Damera, A Dalvand, A Sepanjnia, …
    2021

 

  • Nucleocytoplasmic transport of the RNA-binding protein CELF2 regulates neural stem cell fates
    MJ MacPherson, SL Erickson, D Kopp, P Wen, MR Aghanoori, S Kedia, …
    2021

 

  • CYP2E15B, CYP2E16, CYP2E17B, CYP2E12, and CYP2E1*3 Allele Frequencies in Iranian Populations
    GM Shahriary, H Galehdari, A Jalali, F Zanganeh, SMR Alavi, …
    2012

 

  • Insulin prevents aberrant mitochondrial phenotype in sensory neurons of type 1 diabetic rats
    MR Aghanoori, DR Smith, SR Chowdhury, MG Sabbir, NA Calcutt, …
    2017

 

  • CEBPβ regulation of endogenous IGF-1 in adult sensory neurons can be mobilized to overcome diabetes-induced deficits in bioenergetics and axonal outgrowth
    MR Aghanoori, P Agarwal, E Gauvin, RS Nagalingam, R Bonomo, …
    2022

✅ Conclusion

Dr. Aghanouri stands out as a versatile and impactful scientist whose contributions to neuroscience and genetic medicine hold promise for both understanding and treating complex neurological conditions. His career reflects a strong blend of academic excellence, international collaboration, and leadership in research development. As he continues to build bridges between Iranian and global biosciences, his future work is expected to leave a lasting legacy in molecular neuroscience and translational medicine.

 

Mustafa Nazıroğlu | Cellular Neuroscience | Neuroscience Research Excellence Award

Prof. Mustafa Nazıroğlu | Cellular Neuroscience | Neuroscience Research Excellence Award

Prof. Mustafa Nazıroğlu,  Suleyman Demirel University, Turkey.

Professor Mustafa Nazıroğlu is a distinguished scholar with dual doctorates in Physiology and Neuroscience. Beginning his academic journey at Fırat University and advancing to leadership roles at Süleyman Demirel University, he has become a global authority in the fields of oxidative stress, calcium signaling, and TRP ion channels. His research portfolio includes over 270 peer-reviewed articles and thousands of citations, showcasing a profound impact on cellular neuroscience. Beyond research, he has led major international congresses, served on editorial boards of top journals, and has been honored with numerous awards and fellowships in Europe, Asia, and North America.

Profile

Orcid

 

🎓 Early Academic Pursuits

Professor Mustafa Nazıroğlu embarked on his academic journey with a degree from the Faculty of Veterinary Medicine at Fırat University in 1991. Driven by a profound curiosity for physiological mechanisms, he pursued a Ph.D. in Physiology at the same institution, which he completed between 1992 and 1996. His academic ambitions later led him to earn a second Ph.D. in Neuroscience from Süleyman Demirel University (SDU) in 2018, reflecting his commitment to interdisciplinary scholarship and continuous learning.

🧠 Professional Endeavors in Neuroscience and Biophysics

Currently, Professor Nazıroğlu holds the position of Head of the Department of Biophysics and Neuroscience at SDU Medical Faculty. His professional path has been shaped by a deep dedication to academic leadership, having served in several key roles including department head, director of the Neuroscience Research Centre (NOROBAM), and chair of numerous international scientific congresses. Notably, he has successfully organized the biennial International World Congress of Oxidative Stress, Calcium Signalling and TRP Channels from 2006 to 2020, as well as the International Brain Research School series from 2015 to 2024. His influence has also reached global platforms, including service on the organizing committee for the TEMA-14 Congress in Hubei, China, in 2011.

🔬 Contributions and Research Focus

A prolific researcher, Professor Nazıroğlu has significantly advanced our understanding of oxidative stress, calcium signaling, apoptosis, and ion channel (TRP) physiology. His scientific output includes 274 international research articles, 19 review papers, and six book chapters, collectively amassing over 11,500 citations and earning him a Scopus h-index of 59. He has also contributed as an editorial and reviewing member for leading journals such as Biological Trace Element Research, Scientific Reports (Nature Publishing), Frontiers in Physiology, and Current Neuropharmacology, among others. His research has bridged cellular neuroscience with therapeutic strategies, making him a vital contributor to the global scientific discourse.

🏅 Accolades and Recognition

Throughout his career, Professor Nazıroğlu has received numerous national and international honors, celebrating his scientific achievements and global engagement. These include the NATO Research Fellowship (Germany), the Alexander von Humboldt Fellowship (Germany), and the Young Investigative Scientist Award (USA). He has also been recognized by the Turkish Scientific and Technological Research Council (TÜBİTAK), the Howard Hughes Medical Institute (USA), and was the recipient of the prestigious Khwarizmi International Award (Iran). His visiting professorships at institutions in the UK, Qatar, and Japan further underscore his international reputation and collaboration.

🌍 Impact and Influence

Professor Nazıroğlu’s impact extends beyond academic publishing and conference organization. As a mentor, speaker, and panel member, he has shaped the careers of young neuroscientists and fostered a collaborative global network of researchers in calcium signaling and oxidative biology. His participation in expert advisory boards and scientific panels illustrates the depth of his influence on both research policy and biomedical innovation.

📘 Legacy of Knowledge

With over three decades dedicated to science and education, Professor Nazıroğlu has built a lasting legacy grounded in scientific rigor and visionary leadership. His conferences and educational programs, especially the International Brain Research School, have become cornerstone events for knowledge exchange in neuroscience. He has laid a strong foundation for future advancements in TRP channel research and neurophysiology.

🚀 Future Contributions and Vision

Looking forward, Professor Nazıroğlu continues to guide critical research on cellular responses to oxidative stress and ion channel modulation. His forward-thinking approach, combined with an inclusive scientific philosophy, ensures that he remains a leading voice in shaping the next era of biomedical research. With ongoing collaborative projects and mentorship of emerging scholars, his work is poised to influence both clinical and theoretical frontiers for years to come.

Publication

 

  • Title: Vitamin D Supplementation Modulates Blood and Tissue Zinc, Liver Glutathione and Blood Biochemical Parameters in Diabetic Rats on a Zinc-Deficient Diet
    Authors: Kechrid, Z.; Hamdiken, M.; Nazıroğlu, M.; Flores-Arce, M.
    Year: 2023

 

  • Title: Low molecular weight heparin treatment reduced apoptosis and oxidative cytotoxicity in the thrombocytes of patients with recurrent pregnancy loss and thrombophilia: Involvements of TRPM2 and TRPV1 channels
    Authors: Dal, Y.; Nazıroğlu, M.; Özkaya, M.O.
    Year: 2023

 

  • Title: NMDA Receptor Activation Stimulates Hypoxia-Induced TRPM2 Channel Activation, Mitochondrial Oxidative Stress, and Apoptosis in Neuronal Cell Line: Modular Role of Memantine
    Authors: Kenan Yıldızhan; Mustafa Nazıroğlu
    Year: 2023

 

  • Title: Honey bee venom melittin increases the oxidant activity of cisplatin and kills human glioblastoma cells by stimulating the TRPM2 channel
    Authors: Kemal Ertilav; Mustafa Nazıroğlu
    Year: 2023

 

  • Title: Silver nanoparticles potentiate antitumor and oxidant actions of cisplatin via the stimulation of TRPM2 channel in glioblastoma tumor cells
    Authors: Yener Akyuva; Mustafa Nazıroğlu
    Year: 2023

 

  • Title: A novel antagonist of TRPM2 and TRPV4 channels: Carvacrol
    Author: Nazıroğlu, M.
    Year: 2022

 

  • Title: Amantadine Attenuated Hypoxia-Induced Mitochondrial Oxidative Neurotoxicity, Apoptosis, and Inflammation via the Inhibition of TRPM2 and TRPV4 Channels
    Authors: Öcal, Ö.; Coşar, A.; Nazıroğlu, M.
    Year: 2022

 

  • Title: Eicosapentaenoic acid enhanced apoptotic and oxidant effects of cisplatin via activation of TRPM2 channel in brain tumor cells
    Authors: Öcal, Ö.; Nazıroğlu, M.
    Year: 2022

 

  • Title: Paclitaxel Promotes Oxidative Stress–Mediated Human Laryngeal Squamous Tumor Cell Death through the Stimulation of Calcium and Zinc Signaling Pathways: No Synergic Action of Melatonin
    Authors: Kumbul, Y.Ç.; Nazıroğlu, M.
    Year: 2022

 

  • Title: Protective role of selenium on MPP⁺ and homocysteine-induced TRPM2 channel activation in SH-SY5Y cells
    Authors: Yıldızhan, K.; Nazıroğlu, M.
    Year: 2022

 

🧾 Conclusion

Through an outstanding blend of academic excellence, innovative research, and global collaboration, Professor Nazıroğlu has carved a legacy as a leading figure in neuroscience and biophysics. His efforts in organizing international platforms and mentoring young scientists reflect a career committed to advancing knowledge and fostering global scientific networks. With continued contributions and visionary leadership, he remains a driving force in shaping the future of cellular neurophysiology and therapeutic discovery.

Edyta GLOGOWSKA | Cell Metabolism | Best Researcher Award

Dr. Edyta Glogowska | Cell Metabolism | Best Researcher Award

Dr.  Edyta Glogowska, CNRS-IPMC-UniCA,  France.

Dr. Edyta Glogowska is a passionate and accomplished biomedical researcher with a strong academic background in biotechnology and life sciences. From her early beginnings in dental engineering to earning a PhD in red blood cell physiology from the University Pierre and Marie Curie, her academic journey reflects a deep commitment to advancing human health through science. Her postdoctoral research at the Institute of Molecular and Cellular Pharmacology (IPMC) highlights her expertise in cell physiology, electrophysiology, and molecular biology, with a special focus on macrophage Piezo1 channels and their role in atherosclerosis. She is a skilled communicator and team collaborator, recognized for her academic excellence and contributions to hematology and immunopathology.

Profile

Scopus

🎓 Early Academic Pursuits

Dr. Edyta Glogowska’s journey into the world of life sciences began with a strong foundation in biotechnology and medical sciences. She earned her Master of Engineering in Biotechnology Processing from Wroclaw University of Science and Technology, where she graduated with highest honors. Even earlier, she had already laid a unique cornerstone for her biomedical interests through specialized training as a Dental Engineer at the Marie Curie Medical Vocational School. Her pursuit of deeper scientific knowledge led her to France, where she undertook her PhD in Biological and Life Sciences at the University Pierre and Marie Curie, Paris VI. Conducted at the prestigious Station Biologique in Roscoff, her doctoral research focused on red blood cell physiology and was awarded with the highest honors—a testament to her early dedication and scientific promise.

🔬 Professional Endeavors

Dr. Glogowska’s professional career has been marked by a steadfast commitment to cell and molecular biology, electrophysiology, and the biochemistry of proteins. Her postdoctoral research at the Institute of Molecular and Cellular Pharmacology (IPMC) in Sophia Antipolis (2021–2024) showcases her hands-on expertise with mice experimentation and patch-clamp techniques, placing her at the cutting edge of biomedical research. Working under the guidance of Dr. Eric Honoré, she explored the role of macrophage Piezo1 channels regulated by lipids, a study with far-reaching implications in understanding and potentially treating atherosclerosis.

🧬 Contributions and Research Focus

Throughout her academic and postdoctoral years, Dr. Glogowska has focused her research on the physiology and pathophysiology of cells, particularly red blood cells and immune cells like macrophages. Her interest lies in understanding how cellular mechanisms contribute to broader medical conditions, such as cardiovascular diseases. By integrating electrophysiology with molecular biology, she brings a comprehensive approach to biomedical questions, bridging the gap between basic research and therapeutic application. Her work on Piezo1 not only contributes to our understanding of mechanotransduction in macrophages but also holds promise for future translational research.

🏅 Accolades and Recognition

Dr. Glogowska’s scholarly excellence has been consistently recognized. She graduated with highest honors both for her Master’s and PhD degrees, a rare academic distinction that underscores her dedication and intellectual rigor. She has also been an active member of the French Society of Hematology, aligning herself with leading experts in her field and staying abreast of the latest developments in blood cell research. These accolades reflect her respected standing within the scientific community.

🌍 Impact and Influence

Beyond technical expertise, Dr. Glogowska is praised for her team coordination and communication skills, qualities that have enabled her to contribute meaningfully to collaborative research environments. Her scientific efforts in understanding lipid–ion channel interactions in macrophages directly influence the broader field of cardiovascular immunology. By elucidating the role of Piezo1 channels in inflammatory processes, her research provides foundational knowledge that can inspire novel pharmacological interventions.

🔎 Legacy and Future Contributions

Dr. Glogowska continues to strive toward a future where her research leads to medical breakthroughs in inflammation and cardiovascular disease. She is particularly interested in translational science, where laboratory discoveries transition into clinical applications. Her strong background in biotechnology, dentistry, and molecular biology uniquely equips her to explore cross-disciplinary challenges in human health. As she advances, she aims to bridge research with clinical solutions, contributing to a legacy of innovation in life sciences.

Publication

Title: Potentiation of macrophage Piezo1 by atherogenic 7-ketocholesterol
Authors: Edyta Glogowska, Gregor P. Jose, Ana Rita Dias Araújo, Laurent Yvan-Charvet, Éric R. Honoré
Year: 2025

Title: Piezo1 in PASMCs: Critical for Hypoxia-Induced Pulmonary Hypertension Development
Authors: Fenja Knoepp, Shariq Abid, Amal Houssaïni, Éric R. Honoré, Serge Adnot
Year: 2025

Title: Pharmacological activation of PIEZO1 in human red blood cells prevents Plasmodium falciparum invasion
Authors: Rakhee Lohia, Benoit Allegrini, Laurence Berry, Éric R. Honoré, Kai Wengelnik
Year: 2023

Title: A machine-learning algorithm integrating baseline serum proteomic signatures predicts exercise responsiveness in overweight males with prediabetes
Authors: Candela Diaz-Canestro, Jiarui Chen, Yan Liu, Michael Andrew Tse, Aimin Xu
Year: 2023

Title: Adipose-targeted triiodothyronine therapy counteracts obesity-related metabolic complications and atherosclerosis with negligible side effects
Authors: Kang Chen, Lai Yee Cheong, Yuan Gao, Hannah Xiaoyan Hui, Aimin Xu
Year: 2022

Title: Author Correction: Adipocyte Piezo1 mediates obesogenic adipogenesis through the FGF1/FGFR1 signaling pathway in mice
Authors: Shengpeng Wang, Shuang Cao, Malika Arhatte, Éric R. Honoré, Stefan Offermanns
Year: (Correction Published) — Likely 2021 or 2022

Title: Piezo1 and Piezo2 foster mechanical gating of K2P channels
Authors: Edyta Glogowska, Malika Arhatte, Franck C. Chatelain, Amanda Jane Patel, Éric R. Honoré
Year: 2021

Title: Adipocyte Piezo1 mediates obesogenic adipogenesis through the FGF1/FGFR1 signaling pathway in mice
Authors: Shengpeng Wang, Shuang Cao, Malika Arhatte, Éric R. Honoré, Stefan Offermanns
Year: 2020

Title: Piezo Ion Channels in Cardiovascular Mechanobiology
Authors: Dominique Douguet, Amanda Jane Patel, Aimin Xu, Paul Michel Vanhoutte, Éric R. Honoré
Year: (Not explicitly stated, likely ~2020 based on context)

Title: TMEM33 regulates intracellular calcium homeostasis in renal tubular epithelial cells
Authors: Malika Arhatte, Gihan S. Gunaratne, Charbel El Boustany, Éric R. Honoré, Amanda Jane Patel
Year: 2019

 

 

✅ Conclusion

Driven by curiosity and guided by precision, Dr. Glogowska continues to make meaningful strides in biomedical research. Her work stands at the intersection of basic science and medical application, with the potential to influence future therapeutic strategies for cardiovascular and inflammatory diseases. With her versatile skill set and visionary approach, she is well-positioned to leave a lasting impact on the scientific and medical communities. As she moves forward, Dr. Glogowska aspires to further bridge laboratory discoveries with clinical innovations, fostering a legacy of scientific excellence and translational breakthroughs.

 

Baoying Huang | Pathogen Biology | Best Researcher Award

Baoying Huang | Pathogen Biology | Best Researcher Award

Ms. Baoying Huang,  National Institute for Viral Disease Control and Prevention, China.

Dr. Baoying Huang, a distinguished professor at the Biotech Center for Viral Disease Emergency, China CDC, has over two decades of experience in combating viral diseases. Her expertise lies in vaccine and antiviral drug development for emerging and re-emerging infectious diseases, including COVID-19, monkeypox, and other human coronaviruses.

 

profile

Scopus

🎓 Education Experience

2008.09–2011.07: Doctor of Medicine, Pathogen Biology,Biotech Center for Viral Disease Emergency, China CDC.2005.09–2008.07: Master of Biology, Pathogen Biology,Biotech Center for Viral Disease Emergency, China CDC. 2001.09–2005.07: Bachelor of Biology,
Life Science Department, Nan Hua University, China.

👩‍🔬 Professional Experience

2020.07–Present:  Professor, China CD ,Focus: Vaccine and antiviral drug R&D for SARS-CoV-2 and poxvirus diseases, including COVID-19 and monkeypox. Key Role: Participated in COVID-19 Emergency Projects for SARS-CoV-2 variant monitoring in China.2015.07–2020.07:  Associate Professor, China CDC. Focus: Vaccine and antiviral drug R&D for emerging infectious diseases like influenza and coronaviruses (SARS-CoV, MERS-CoV).2015.04–2015.06:  Assistant Professor, China CDC. Global Health Support Program: Worked in Sierra Leone to establish Ebola lab systems, improving public health infrastructure.2011.07–2015.07: Assistant Professor, China CDC. Focus: Pathogenic molecular mechanisms of influenza viruses, pseudo-virus applications, and gene-engineered vaccines. 2005.09–2011.07:  Graduate Researcher, IVDC, China CDC. Specialization: Developing universal influenza vaccines for cross-protection against various strains.

🔬 Research Focus

Baoying Huang’s work is dedicated to:Vaccine Development: COVID-19 vaccines (BBIBP-CorV, mRNA vaccines) and pan-orthopoxvirus solutions.Emerging Diseases: Countermeasures for SARS-CoV-2, monkeypox, and other viral threats.Diagnostics: Whole-genome sequencing and real-time PCR for virus detection and monitoring.Therapeutics: Screening novel antivirals targeting viruses like SARS-CoV-2 and monkeypox.Key achievements include:Leading the development of Sinopharm COVID-19 vaccine, later approved by WHO for Emergency Use Listing.Establishing monitoring systems for SARS-CoV-2 variants and assessing their impact on public health measures. Advancing monkeypox vaccine research and identifying promising antiviral compounds against orthopoxviruses.

📚 Publications

  • Title: Molecular architecture of monkeypox mature virus
    • Authors: Hong, Y., Huang, B., Zhang, J., Tan, W., Li, S.
    • Year: 2024

 

  • Title: Vaccinia virus Tiantan strain blocks host antiviral innate immunity and programmed cell death by disrupting gene expression
    • Authors: Wu, C., Zhang, Z., Li, Z., Deng, Y., Tan, W.
    • Year: 2024

 

  • Title: A clinically used anti-human papilloma virus agent (3-hydroxyphthalic anhydride-modified bovine β-lactoglobulin) has a potential for topical application to prevent sexual transmission of monkeypox virus
    • Authors: Sha, Y., Huang, B., Hua, C., Tan, W., Jiang, S.
    • Year: 2024

 

  • Title: Development of a multiplex real-time PCR assay for the simultaneous detection of mpox virus and orthopoxvirus infections
    • Authors: Fan, Z., Xie, Y., Huang, B., Tan, W., Guo, F.
    • Year: 2024

 

  • Title: Accurate determination of the whole genome sequencing and open reading frames composition of non-replicating Tiantan strain of vaccinia virus based on novel long read sequencing platform
    • Authors: Zhang, Z., Wu, C., Li, H., Huang, B., Tan, W.
    • Year: 2024

 

  • Title: Characterization of whole genomes from recently emerging Mpox cases in several regions of China, 2023
    • Authors: Wu, C., Cui, L., Pan, Y., Wang, Q., Tan, W.
    • Year: 2024

 

  • Title: Intranasal immunization with single-dose vaccine based on recombinant influenza virus H1N1 expressing the extracellular domain of respiratory syncytial virus G protein induces robust immunity and protection in mice
    • Authors: Han, R., Wang, D., Wang, T., Huang, B., Tan, W.
    • Year: 2024

 

  • Title: Rapid identification of full-length genome and tracing variations of monkeypox virus in clinical specimens based on mNGS and amplicon sequencing
    • Authors: Wu, C., A, R., Ye, S., Lu, J., Tan, W.
    • Year: 2024

 

  • Title: Long-lasting humoral and cellular memory immunity to vaccinia virus Tiantan provides pre-existing immunity against mpox virus in Chinese population
    • Authors: Li, M., Guo, Y., Deng, Y., Gao, G.F., Liu, J.
    • Year: 2024

 

  • Title: Identification of the VP37 pocket of monkeypox virus as a promising target for pan-orthopoxvirus inhibitors through virtual screening and antiviral assays
    • Authors: Huo, S., Wu, L., Huang, B., Xu, Z., Tan, W.
    • Year: 2024

 

Conclusion

Dr. Huang’s career exemplifies unwavering dedication to improving public health through innovation in vaccine development, antiviral research, and diagnostic technologies. Her contributions to tackling global health challenges, such as the COVID-19 pandemic and monkeypox outbreaks, have significantly impacted infectious disease prevention and control worldwide. As viruses continue to evolve, her pioneering work remains a cornerstone in safeguarding global health.